2Muir KW, Lees KR. Clinical experience with excitatory amino acid antagonist drugs[J].Stroke,1995,26:503-513.
3Watanbe T, Yuki S, Egawa M, et al. Protective effects of MCI-186 on cerebral ischemia: possible involvement of free radical scavenging and antioxidant actions[J]. J Phatmacol Exp Ther,1994,268:597-604.
4Abe K, Yuki S, Kogure K. Strong attenuation of ischemic and posteschemic brain in rats by a novel free radical scavenger[J]. Stroke,1988,19:480-485.
5Nishi H, Watanabe T, Sakurai H, et al. Effect of MCI-186 on brain edema in rats[J]. Stroke, 1989, 20:1236-1240.
6Abe K, et al: Strong attenuation of ischemic edema in rata. Stroke, 20:1236-1240,1989 and postischemic brain edema in rats by a novel free radical scavenger. Stroke 1988, 19:480-485,Nishi, H. Et al.: Effect of MCI-186 on brain edema in rats. Stroke, 20:1236-1240,1989.
7Yamamoto, Y.et.: Delayed neuronal death prevented by inhibition of increased hydroxyl radical formation in a transient cerebral ischemis. Brain Res, 1997,762:240.
8Watanabe, T. et al. Protective effects of MCI-186 on cerehral ischemia: Possible involvement of free radical scavenging and antioxidant actions. J. Pharmacol. Exp. Ther, 1994,268:1597-1604.
9Nishi, H. et sl.: Effect of MCI-186 on brain.
10Peters O, et al: Increased formation of reactive oxygen speciesafter permanent and reversible middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metsb 1998,18:196-205.
